Barbara‐ann Guinn

2.5k total citations
89 papers, 1.8k citations indexed

About

Barbara‐ann Guinn is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Barbara‐ann Guinn has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 35 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Barbara‐ann Guinn's work include Immunotherapy and Immune Responses (34 papers), CAR-T cell therapy research (20 papers) and Acute Myeloid Leukemia Research (19 papers). Barbara‐ann Guinn is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), CAR-T cell therapy research (20 papers) and Acute Myeloid Leukemia Research (19 papers). Barbara‐ann Guinn collaborates with scholars based in United Kingdom, Germany and Canada. Barbara‐ann Guinn's co-authors include Ghulam J. Mufti, Adam Cheuk, Ken Mills, Neil L. Berinstein, Yannis Pappas, Dong Pang, Tania H. Watts, Mark DeBenedette, Farzin Farzaneh and Rose Ann Padua and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Barbara‐ann Guinn

84 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara‐ann Guinn United Kingdom	21	701	690	485	463	224	89	1.8k
Valentina Salvestrini Italy	22	721 1.0×	527 0.8×	338 0.7×	321 0.7×	80 0.4×	41	1.9k
Keisuke Kataoka Japan	31	718 1.0×	1.2k 1.7×	683 1.4×	877 1.9×	266 1.2×	145	3.0k
Kenneth S. Zuckerman United States	24	343 0.5×	598 0.9×	318 0.7×	469 1.0×	98 0.4×	67	1.5k
Jae-Hung Shieh United States	20	334 0.5×	959 1.4×	352 0.7×	303 0.7×	93 0.4×	36	1.6k
Hsun Teresa Ku United States	20	490 0.7×	797 1.2×	424 0.9×	509 1.1×	381 1.7×	51	2.3k
Elizabeth O’Donnell United States	25	218 0.3×	1.2k 1.7×	815 1.7×	636 1.4×	116 0.5×	116	2.4k
Dana E. Cullen United States	11	320 0.5×	1.5k 2.2×	329 0.7×	751 1.6×	138 0.6×	15	2.2k
Jonathan M. Gerber United States	19	187 0.3×	813 1.2×	384 0.8×	424 0.9×	125 0.6×	57	1.7k
Cornelia Brendel Germany	28	450 0.6×	776 1.1×	598 1.2×	1.0k 2.2×	360 1.6×	82	2.6k
Andrea Kolbus Austria	26	368 0.5×	1.4k 2.1×	476 1.0×	163 0.4×	239 1.1×	39	2.5k

Countries citing papers authored by Barbara‐ann Guinn

Since Specialization

Citations

This map shows the geographic impact of Barbara‐ann Guinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara‐ann Guinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara‐ann Guinn more than expected).

Fields of papers citing papers by Barbara‐ann Guinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara‐ann Guinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara‐ann Guinn. The network helps show where Barbara‐ann Guinn may publish in the future.

Co-authorship network of co-authors of Barbara‐ann Guinn

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara‐ann Guinn. A scholar is included among the top collaborators of Barbara‐ann Guinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara‐ann Guinn. Barbara‐ann Guinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greiner, Jochen, et al.. (2024). Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia. Cancers. 16(20). 3443–3443. 2 indexed citations

Guinn, Barbara‐ann, et al.. (2024). Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis. BMJ evidence-based medicine. 29(6). 385–393. 1 indexed citations

Guinn, Barbara‐ann, et al.. (2024). Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis. medRxiv. 1 indexed citations

Rigby, Alan S., et al.. (2024). Are There Non-Invasive Biomarker(s) That Would Facilitate the Detection of Ovarian Torsion? A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 25(21). 11664–11664. 1 indexed citations

Hart, Simon P., et al.. (2024). Can Tumour Antigens Act as Biomarkers for the Early Detection of Non-Small Cell Lung Cancer?. SHILAP Revista de lepidopterología. 4(2). 87–100. 1 indexed citations

Guinn, Barbara‐ann, et al.. (2023). A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24(11). 9667–9667. 2 indexed citations

Guinn, Barbara‐ann, Patrick J. Schuler, Hubert Schrezenmeier, et al.. (2023). A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 24(11). 9285–9285. 4 indexed citations

Greiner, Jochen, Patrick J. Schuler, Susanne Hofmann, et al.. (2022). Enhanced stimulation of antigen‐specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti‐programmed death 1 antibody. British Journal of Haematology. 198(5). 866–874. 12 indexed citations

Rigby, Alan S., et al.. (2022). Accuracy and utility of blood and urine biomarkers for the noninvasive diagnosis of endometriosis: a systematic literature review and meta-analysis. Repository@Hull (Worktribe) (University of Hull). 4(2). 116–130. 11 indexed citations

10.

Guinn, Barbara‐ann, et al.. (2021). Ovarian Cancer in the Sudan - Identifying the Social and Clinical Factors that Prevent an Early Diagnosis. Repository@Hull (Worktribe) (University of Hull). 8(5).

11.

Greiner, Jochen, Lars Bullinger, Robert K. Hills, et al.. (2021). Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients. International Journal of Molecular Sciences. 22(19). 10482–10482. 7 indexed citations

12.

Pappas, Yannis, et al.. (2021). Can Non-invasive Biomarkers Lead to an Earlier Diagnosis of Alzheimer’s Disease?. Current Alzheimer Research. 18(11). 908–913. 5 indexed citations

13.

Wilkinson, Holly N., Barbara‐ann Guinn, & Matthew J. Hardman. (2021). Combined Metallomics/Transcriptomics Profiling Reveals a Major Role for Metals in Wound Repair. Frontiers in Cell and Developmental Biology. 9. 788596–788596. 4 indexed citations

14.

Boullosa, Laurie Freire, Viggo Van Tendeloo, Evelien Smits, et al.. (2020). New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia. Cancer Immunology Immunotherapy. 69(5). 867–877. 3 indexed citations

15.

Bonney, Stephanie A., et al.. (2020). Serum profiling identifies ibrutinib as a treatment option for young adults with B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 189(3). 500–512. 4 indexed citations

16.

Guinn, Barbara‐ann, et al.. (2005). Bcl-2 and c-Myc co-operate in the Epstein – Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity. Leukemia & lymphoma. 46(4). 581–592. 2 indexed citations

17.

Guinn, Barbara‐ann. (2004). Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression. Cancer Immunology Immunotherapy. 54(3). 290–295. 1 indexed citations

18.

Liggins, Amanda P., Barbara‐ann Guinn, Chris S.R Hatton, Karen Pulford, & Alison H. Banham. (2004). Serologic detection of diffuse large B‐cell lymphoma‐associated antigens. International Journal of Cancer. 110(4). 563–569. 22 indexed citations

19.

Fouillard, L, et al.. (1998). Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. Hematology. 3(5). 347–354. 1 indexed citations

20.

Guinn, Barbara‐ann & Ken Mills. (1997). p53 Mutations, Methylation and Genomic Instability in the Progression of Chronic Myeloid Leukaemia. Leukemia & lymphoma. 26(3-4). 211–226. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact